Clinical Trials Insight: 700039566
Latest Information Update: 08 Dec 2008
Price :
$35 *
At a glance
- Drugs Faldaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 08 Dec 2008 New trial record.
- 08 Dec 2008 Results have been reported.